Skip to main content
padlock icon - secure page this page is secure

Open Access Health care gaps in the global burden of drug-resistant tuberculosis

Download Article:
 Download
(PDF 776.2 kb)
 
The drug-resistant tuberculosis (DR-TB) cascade—from estimated or incident cases to numbers successfully treated or disease-free survival—has long been characterised by sharp declines at each step in the cascade. The losses along the cascade vary across different settings, and the reasons why some countries have a higher burden of DR-TB are complex and multifactorial; broadly, weak health systems, inadequate financing and poverty all impact differential access to DR-TB care. Within a human rights framework that mandates the right to health and the right to benefit from scientific progress, the aim of this review is to focus on describing inequities in access to DR-TB care at critical points in the cascade.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DR-TB diagnostic gaps; DR-TB human rights law; DR-TB new drugs and shorter regimen; DR-TB treatment gaps

Document Type: Research Article

Affiliations: 1: Center for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town 2: Division of Medical Microbiology and the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa 3: McGill International TB Centre, McGill University, Montreal, Quebec, Canada 4: College of Liberal Arts and Sciences, Wayne State University, Detroit, Michigan 5: Northwestern Pritzker School of Law, Chicago, Illinois, USA 6: International Union Against TB and Lung Disease, Paris, France

Publication date: February 1, 2019

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more